Clinical Trial Update: Multi-CAR T Cell Therapy for Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A multi-CAR T cell therapy is being studied in Phase 1/Phase 2 for acute myeloid leukemia; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Multi-CAR T Cell Therapy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING